Intracardiac Hemostasis and Fibrinolysis Parameters in Patients with Atrial Fibrillation. - Wikidata - awgldk - TriplyDB

Intracardiac Hemostasis and Fibrinolysis Parameters in Patients with Atrial Fibrillation.

Intracardiac Hemostasis and Fibrinolysis Parameters in Patients with Atrial Fibrillation.

http://www.wikidata.org/entity/Q33872912

about

Soluble Fibrin Monomer Complex and Prediction of Cardiovascular Events in Atrial Fibrillation: The Observational Murcia Atrial Fibrillation Project.

P2860

Q52345203-CA6010EA-819C-4BDB-BAC4-2450DDE85D1C

P2860

Intracardiac Hemostasis and Fibrinolysis Parameters in Patients with Atrial Fibrillation.

http://www.wikidata.org/entity/Q33872912

description

2017 nî lūn-bûn

@nan

2017 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Intracardiac Hemostasis and Fibrinolysis Parameters in Patients with Atrial Fibrillation.

@ast

Intracardiac Hemostasis and Fibrinolysis Parameters in Patients with Atrial Fibrillation.

@en

type

label

Intracardiac Hemostasis and Fibrinolysis Parameters in Patients with Atrial Fibrillation.

@ast

Intracardiac Hemostasis and Fibrinolysis Parameters in Patients with Atrial Fibrillation.

@en

prefLabel

Intracardiac Hemostasis and Fibrinolysis Parameters in Patients with Atrial Fibrillation.

@ast

Intracardiac Hemostasis and Fibrinolysis Parameters in Patients with Atrial Fibrillation.

@en

P1433

Q33872912-FAA7FAC8-C502-4EA0-8CB8-B4992B90210D

P1476

Q33872912-D16C8F2E-16A3-4974-BFF0-00377D2DE1C5

P2093

Q33872912-3BDF7632-3654-4B0C-861A-A5FE2A3FBA2A

Q33872912-3F8E49C6-FB7D-4EF5-8C61-C927675A024E

Q33872912-42CB4582-E31E-4840-9D6D-F36455733D9C

Q33872912-55A990B5-F962-4F4C-B64B-E16B70525A5C

Q33872912-9EA0DF21-2E44-4329-88AC-110E514CFDB4

Q33872912-A512596B-F3A6-4D8E-A9EB-A185E88159DA

Q33872912-F7C7391A-13A6-44AC-B8A2-BD300893B4D8

Q33872912-FF892576-FD36-412E-8FC5-38BFE9A21268

P2860

Q33872912-04A837BB-5D95-4B06-AEA8-C1997C91E52A

Q33872912-0538A9ED-780E-4AA1-8D70-5EF75894CF67

Q33872912-0E4EA3C5-EC73-469C-97EB-74F524AC060E

Q33872912-3178A709-F265-4626-84B0-6ABF84079677

Q33872912-39CF8ED0-761B-40C4-B3B6-288A94298673

Q33872912-3F190F8F-7449-4E58-BD46-A9795ADDA504

Q33872912-41A31117-295B-4542-AAB6-8D942511911D

Q33872912-44E27CCC-815B-4F49-A7CD-73037846168D

Q33872912-53556F7B-9311-40AD-A0BD-73D2627E0BFC

Q33872912-54F8BEEE-F54B-45BE-8A29-AD8D156F02D3

P304

Q33872912-DF74E3D8-FC4C-4313-B6C5-6CA0AEB95E5D

P31

Q33872912-7B628039-4E68-46B7-A4E0-136903873B8F

P356

Q33872912-C9CE70B4-03AC-4F57-BBE2-D7C649482501

P407

Q33872912-B1CAD161-FA04-477D-831E-2CDC56F043B0

P478

Q33872912-2E835B75-5D30-44C6-AFBE-156F87658CF6

P50

Q33872912-7479667C-9C79-4487-94A6-0006787F581B

Q33872912-9BB4DE0B-B670-4A97-9D64-8E8B1C295E8F

Q33872912-A5991BB3-D148-4C40-84BB-BF68A9896ECC

P577

Q33872912-EB96F702-C02A-42E9-8B32-7AECEDFC66AE

P698

Q33872912-5CF1550C-29D8-42E6-8B11-0D475ADD041D

P932

Q33872912-99F2EF5A-F463-4816-9DC2-5C6AA314E2C6

P356

P1433

BioMed Research International

P1476

Intracardiac Hemostasis and Fibrinolysis Parameters in Patients with Atrial Fibrillation.

@en

P2093

Alexandra Kiss

http://www.w3.org/2001/XMLSchema#string

Edina Nagy-Baló

http://www.w3.org/2001/XMLSchema#string

Ferenc Sarkady

http://www.w3.org/2001/XMLSchema#string

Kitti Bernadett Kovács

http://www.w3.org/2001/XMLSchema#string

László Muszbek

http://www.w3.org/2001/XMLSchema#string

Orsolya Hajas

http://www.w3.org/2001/XMLSchema#string

Zoltán Csanádi

http://www.w3.org/2001/XMLSchema#string

Zsuzsanna Bereczky

http://www.w3.org/2001/XMLSchema#string

P2860

Inflammation and C-reactive protein in atrial fibrillation: cause or effect?

Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation

Nonvalvular atrial fibrillation: evidence for a prothrombotic state.

Increased tissue plasminogen activator levels in patients with nonvalvular atrial fibrillation

Functional architecture of Weibel-Palade bodies.

Peri-procedural interrupted oral anticoagulation for atrial fibrillation ablation: comparison of aspirin, warfarin, dabigatran, and rivaroxaban.

Effects of radiofrequency catheter ablation of atrial fibrillation on soluble P-selectin, von Willebrand factor and IL-6 in the peripheral and cardiac circulation

Hemostatic markers are associated with the risk and prognosis of atrial fibrillation: the ARIC study.

Fibrinolytic function and atrial fibrillation.

Association of hemostatic markers with atrial fibrillation: a meta-analysis and meta-regression.

P304

3678017

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2017/3678017

http://www.w3.org/2001/XMLSchema#string

P407

P478

2017

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-06-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28713823

http://www.w3.org/2001/XMLSchema#string

P932

5497646

http://www.w3.org/2001/XMLSchema#string